| Tracking the evolution of non–small-cell lung cancer M Jamal-Hanjani, GA Wilson, N McGranahan, NJ Birkbak, TBK Watkins, ... New England Journal of Medicine 376 (22), 2109-2121, 2017 | 2209 | 2017 |
| Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution C Abbosh, NJ Birkbak, GA Wilson, M Jamal-Hanjani, T Constantin, ... Nature 545 (7655), 446-451, 2017 | 1714 | 2017 |
| Allele-specific HLA loss and immune escape in lung cancer evolution N McGranahan, R Rosenthal, CT Hiley, AJ Rowan, TBK Watkins, ... Cell 171 (6), 1259-1271. e11, 2017 | 1183 | 2017 |
| Fc effector function contributes to the activity of human anti-CTLA-4 antibodies FA Vargas, AJS Furness, K Litchfield, K Joshi, R Rosenthal, E Ghorani, ... Cancer cell 33 (4), 649-663. e4, 2018 | 544 | 2018 |
| C-Myc 5′ untranslated region contains an internal ribosome entry segment M Stoneley, FEM Paulin, JPC Le Quesne, SA Chappell, AE Willis Oncogene 16 (3), 423-428, 1998 | 437 | 1998 |
| Fc-optimized anti-CD25 depletes tumor-infiltrating regulatory T cells and synergizes with PD-1 blockade to eradicate established tumors FA Vargas, AJS Furness, I Solomon, K Joshi, L Mekkaoui, MH Lesko, ... Immunity 46 (4), 577-586, 2017 | 417 | 2017 |
| BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received SJ Dawson, N Makretsov, FM Blows, KE Driver, E Provenzano, ... British journal of cancer 103 (5), 668-675, 2010 | 374 | 2010 |
| Partial restoration of protein synthesis rates by the small molecule ISRIB prevents neurodegeneration without pancreatic toxicity M Halliday, H Radford, Y Sekine, J Moreno, N Verity, J Le Quesne, ... Cell death & disease 6 (3), e1672-e1672, 2015 | 342 | 2015 |
| Tracking genomic cancer evolution for precision medicine: the lung TRACERx study M Jamal-Hanjani, A Hackshaw, Y Ngai, J Shaw, C Dive, S Quezada, ... PLoS biology 12 (7), e1001906, 2014 | 304 | 2014 |
| Analysis of the c-myc IRES; a potential role for cell-type specific trans-acting factors and the nuclear compartment M Stoneley, T Subkhankulova, JPC Le Quesne, MJ Coldwell, CL Jopling, ... Nucleic acids research 28 (3), 687-694, 2000 | 260 | 2000 |
| Geospatial immune variability illuminates differential evolution of lung adenocarcinoma K AbdulJabbar, SEA Raza, R Rosenthal, M Jamal-Hanjani, S Veeriah, ... Nature medicine 26 (7), 1054-1062, 2020 | 235 | 2020 |
| Micro-RNAs and breast cancer J Le Quesne, C Caldas Molecular oncology 4 (3), 230-241, 2010 | 197 | 2010 |
| The path to a better biomarker: application of a risk management framework for the implementation of PD‐L1 and TILs as immuno‐oncology biomarkers in breast cancer clinical … PI Gonzalez‐Ericsson, ES Stovgaard, LF Sua, E Reisenbichler, Z Kos, ... The Journal of pathology 250 (5), 667-684, 2020 | 171 | 2020 |
| Challenges in molecular testing in non-small-cell lung cancer patients with advanced disease CT Hiley, J Le Quesne, G Santis, R Sharpe, DG de Castro, G Middleton, ... The Lancet 388 (10048), 1002-1011, 2016 | 163 | 2016 |
| Characterisation of microRNA expression in post-natal mouse mammary gland development S Avril-Sassen, LD Goldstein, J Stingl, C Blenkiron, J Le Quesne, I Spiteri, ... BMC genomics 10, 1-15, 2009 | 160 | 2009 |
| Identification of a motif that mediates polypyrimidine tract-binding protein-dependent internal ribosome entry SA Mitchell, KA Spriggs, M Bushell, JR Evans, M Stoneley, ... Genes & development 19 (13), 1556-1571, 2005 | 158 | 2005 |
| Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma L Au, E Hatipoglu, MR de Massy, K Litchfield, G Beattie, A Rowan, ... Cancer cell 39 (11), 1497-1518. e11, 2021 | 157 | 2021 |
| The malignant phenotype in breast cancer is driven by eIF4A1-mediated changes in the translational landscape A Modelska, E Turro, R Russell, J Beaton, T Sbarrato, K Spriggs, J Miller, ... Cell death & disease 6 (1), e1603-e1603, 2015 | 157 | 2015 |
| TGFβ induces the formation of tumour-initiating cells in claudinlow breast cancer A Bruna, W Greenwood, J Le Quesne, A Teschendorff, ... Nature communications 3 (1), 1055, 2012 | 128 | 2012 |
| p53 mutants cooperate with HIF-1 in transcriptional regulation of extracellular matrix components to promote tumor progression I Amelio, M Mancini, V Petrova, RA Cairns, P Vikhreva, S Nicolai, A Marini, ... Proceedings of the National Academy of Sciences 115 (46), E10869-E10878, 2018 | 123 | 2018 |
